Breath analyzer detects lung cancer

Key points
- A sort of "electronic nose" can identify patients with lung cancer by detecting specific compounds in their breath, investigators report.
- As the name implies, an electronic nose is a device that analyzes volatile organic compounds.
- In the study reported in the American Journal of Respiratory and Critical Care Medicine, investigators first "trained" the device by having it analyze the breath of 14 patients with lung cancer and 45 healthy controls.
- This exercise showed that there were indeed distinct properties to the breath of lung cancer patients, Dr.
A sort of "electronic nose" can identify patients with lung cancer by detecting specific compounds in their breath, investigators report.
As the name implies, an electronic nose is a device that analyzes volatile organic compounds. These devices, which have been used in the food industry and other commercial applications, rely on chemical vapor sensors that are capable of detecting subtle differences in odorant molecules.
In the study reported in the American Journal of Respiratory and Critical Care Medicine, investigators first "trained" the device by having it analyze the breath of 14 patients with lung cancer and 45 healthy controls.
This exercise showed that there were indeed distinct properties to the breath of lung cancer patients, Dr. Serpil C. Erzurum, from the Cleveland Clinic Foundation in Ohio, and colleagues found.
The data from the learning process were then applied to an investigation of a second group of 76 subjects - 14 with and 62 without lung cancer. The nose correctly identified 71 percent of the people with lung cancer and 92 percent of those that did not have the condition.
"This study demonstrates the feasibility of clinical monitoring of volatile organic compounds in exhaled breath using a multisensor electronic nose as a relatively convenient and noninvasive test in patients with suspected lung cancer," the authors conclude.
SOURCE: American Journal of Respiratory and Critical Care Medicine, June 2005.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsEarly recall rates decline after second round of lung cancer screening
The German Lung Cancer Screening Intervention Trial (LUSI) shows that the early repeat scan rate for suspicious findings decreased by more than 80% with the second and subsequent low-dose computed tomography (LDCT)…
19 March 2015
NewsLocal treatment of lung cancer
Nanoparticles are extremely small particles that can be modified for a variety of uses in the medical field. For example, nanoparticles can be engineered to be able to transport medicines specifically to the disease…
6 March 2015
NewsStudy suggests need for more sensitive lung cancer screening criteria
An analysis of lung cancer incidence and screening found a decline in the proportion of patients with lung cancer meeting high-risk screening criteria, suggesting that an increasing number of patients with lung cancer…
25 February 2015


